openPR Logo
Press release

The Lanier Law Firm Leads National Conference on Asbestos Litigation

01-04-2011 12:52 PM CET | Politics, Law & Society

Press release from: The Lanier Law Firm

HOUSTON – Trial attorney Richard Meadow, who leads the New York office of The Lanier Law Firm, is serving as Co-Chair of an upcoming national conference on asbestos litigation.

The law firm is one of the lead sponsors for “Trying an Asbestos Case – How to Get the ‘W’,” an informative program for the nation’s top asbestos attorneys taking place on Jan 25, 2011, at the Hub Cira Centre in Philadelphia. The conference includes presentations and panel discussions featuring dozens of the country’s leading practitioners in asbestos law.

The Lanier Law Firm founder Mark Lanier will headline a panel discussion on opening statements, including insights from three sitting judges on strategies for compelling openings, common mistakes to avoid and paths to take for certain kinds of cases. Dr. Robert E. Leone, an accomplished attorney and in-house trial psychologist at The Lanier Law Firm, will participate in a panel discussion on “Preparing the Plaintiff and Defendant for Deposition and Trial.”

“Unfortunately, thousands of people continue to be affected by the dangers of asbestos,” says Mr. Lanier. “I am proud that our firm is helping lead the charge in helping these victims, and this conference is a wonderful example of lawyers joining together to better represent our clients.”

The Lanier Law Firm’s Toxic Exposure and Asbestos practice is one of the largest in the country, featuring 25 lawyers with more than 1,000 pending asbestos claims in courts across the United States. The firm also maintains the website www.NationalMesotheliomaLawyer.com, which offers information and advice on the everyday dangers of asbestos exposure.

For more information, please contact J.D. Cargill at 713-659-5200.

With offices in Los Angeles, Palo Alto, Houston and New York, The Lanier Law Firm is committed to addressing client concerns with effective and innovative solutions in courtrooms across the country. The firm is composed of outstanding trial attorneys with decades of experience handling cases involving asbestos exposure, pharmaceutical liability, intellectual property, business litigation, product liability, toxic exposure, and maritime law.

J.D. Cargill
The Lanier Law Firm
6810 FM 1960 West
Houston, TX 77069
713-659-5200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Lanier Law Firm Leads National Conference on Asbestos Litigation here

News-ID: 157265 • Views:

More Releases for Trial

Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period. Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical